Sort   by:  
 Page size 
UnknownPhase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial.
Not available
S-EPMC3612594 | biostudies-literature
UnknownPhase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.
Not available
S-EPMC3402509 | biostudies-literature
UnknownCetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.
Not available
S-EPMC3525135 | biostudies-literature
UnknownLaryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers.
Not available
S-EPMC6554412 | biostudies-literature
UnknownA phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
Not available
S-EPMC3135694 | biostudies-literature
UnknownNonlinear Lifespan Trajectories of Memory and Fluid Reasoning: A Longitudinal GAMM Study.
Not available
S-EPMC12776469 | biostudies-literature
UnknownBrain resilience to targeted attack of resting BOLD networks as a measure of cognitive reserve.
Not available
S-EPMC12801055 | biostudies-literature
UnknownBrain Resilience to Targeted Attack of Resting BOLD Networks as a Measure of Cognitive Reserve.
Not available
S-EPMC11643323 | biostudies-literature
UnknownNeural similarity across task load relates to cognitive reserve and brain maintenance measures on the Letter Sternberg task: a longitudinal study.
Not available
S-EPMC9925407 | biostudies-literature
UnknownValidation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302).
Not available
S-EPMC7724483 | biostudies-literature
Sort   by:  
 Page size